Population Pharmacokinetics‐Pharmacodynamics and Exposure‐Response of Ropeginterferon Alfa‐2b in Chinese and Japanese Patients With Polycythemia Vera

Population Pharmacokinetics‐Pharmacodynamics and Exposure‐Response of Ropeginterferon Alfa‐2b in Chinese and Japanese Patients With Polycythemia Vera

ABSTRACT Ropeginterferon alfa‐2b (ropeg) represents a new‐generation interferon‐based therapy approved for polycythaemia vera (PV) treatment. This study aimed to elucidate its population pharmacokinetics‐pharmacodynamics (PopPK‐PD) and exposure‐response (E‐R) relationships. A PopPK model was develop...

Full description

Saved in:

Bibliographic Details
Main Authors:	Albert Qin, Kazuya Shimoda, Shanshan Suo, Rongfeng Fu, Keita Kirito, Daoxiang Wu, Jason Liao, Haoqi Chen, Lei Wu, Xia Su, Yucheng Gao, Toshiaki Sato, Yaning Li, Jingjing Zhang, Weihong Shen, Wei Wang, Lei Zhang, Jie Jin, Norio Komatsu
Format:	Article
Language:	English
Published:	Wiley 2025-06-01
Series:	Pharmacology Research & Perspectives
Subjects:	complete hematologic response (CHR) exposure‐response (E‐R) JAK2V617F allele burden polycythemia vera (PV) population pharmacokinetics‐pharmacodynamics (PopPK‐PD) Ropeginterferon alfa‐2b (ropeg)
Online Access:	https://doi.org/10.1002/prp2.70109
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic Drug Monitoring-Based Population Pharmacokinetics of Amikacin in Patients at a Teaching Hospital
by: Nadine Arnold Steffens, et al.
Published: (2025-05-01)

Improving Individualized Salbutamol Treatment: A Population Pharmacokinetic Model for Oral Salbutamol in Virtual Patients
by: Lara Marques, et al.
Published: (2024-12-01)

A higher JAK2V617F allele burden may be a risk factor for hemorrhagic events in younger patients with polycythemia vera
by: Chiho Furuya, et al.
Published: (2024-12-01)

Study of Patients with Polycythemia Vera in JAK2V617F and Mutated and Unmutated Status along with their Anxiety and Worried Thoughts: A Single-center Experience from Eastern India
by: Rishu Vidhatri, et al.
Published: (2024-12-01)

POLYCYTHEMIA VERA IDENTIFIED IN A PATIENT WITH RESTENOSIS OF THE SUPERFICIAL FEMORAL ARTERY. CLINICAL CASE AND REVIEW OF THE LITERATURE
by: G. Sh. Safuanova, et al.
Published: (2017-05-01)

Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study
by: Long Chang, et al.
Published: (2025-05-01)

Correction: Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study
by: Long Chang, et al.
Published: (2025-06-01)

Machine learning approach for personalized vancomycin steady-state trough concentration prediction: a superior approach over Bayesian population pharmacokinetic model
by: Ting Hu, et al.
Published: (2025-06-01)

Investigation into the pharmacodynamics and pharmacokinetics of recombinant human interferon alfa-2b vaginal suppository following process optimization in chinese rhesus macaque
by: Xueyan Zhang, et al.
Published: (2025-05-01)

Polycythemia Vera: New Diagnostic Concept and Its Types
by: AM Kovrigina, et al.
Published: (2016-04-01)

Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone,
by: Beatrice Borsellino, et al.
Published: (2022-06-01)

Screening for Janus kinase-2 exon 12 mutations among Janus kinase-2 V617F-negative polycythemia vera suspected Iraqi patients
by: Mushtaq M. Khazeem, et al.
Published: (2024-12-01)

All we know about polycythemia vera: literature review and own experience
by: K. M. Abdulkadyrov, et al.
Published: (2015-10-01)

Ovarian Hyperthecosis Presenting as Polycythemia
by: Gayatri Jaiswal, MD, et al.
Published: (2025-03-01)

Polycythemia in Nephrotic Syndrome
by: Anagha Auradkar, et al.
Published: (2025-01-01)

Masked polycythemia vera manifested by splanchnic venous thrombosis during pregnancy: a clinical case
by: M. Yu. Nadinskaia, et al.
Published: (2022-05-01)

Hydronephrosis-Induced Polycythemia with Low Erythropoietin Level: A Case Report and Literature Review
by: Chia-Cheng Chang, et al.
Published: (2024-12-01)

CARDIOVASCULAR RISK IN ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA: THROMBOTIC RISK AND SURVIVAL
by: Vincenzo Accurso, et al.
Published: (2020-01-01)

In vivo pharmacokinetic and pharmacodynamic study and cutoff of florfenicol against Riemerella anatipestifer in ducks
by: Hui-Lin Zhang, et al.
Published: (2025-01-01)

From Diagnosis to Health Practice: Polycythemia Vera. A Literature Review
by: Katarzyna Siekaniec, et al.
Published: (2025-07-01)

Early virologic response to сеpeginterferon alfa-2b in combination with ribavirin in treatment of patients with chronic hepatitis C
by: O. O. Znoyko, et al.
Published: (2014-09-01)

Genetic Markers of Hereditary Thrombophilia and Risk of Thrombotic Complications in Patients with Polycythemia Vera
by: DI Shikhbabaeva, et al.
Published: (2017-01-01)

A case of chorea with cognitive impairment associated with polycythemia vera
by: Yu. A. Shpilyukova, et al.
Published: (2023-12-01)

Polycythemia Vera in Pregnancy: A Descriptive Review of the Literature
by: Nicole Xu, et al.
Published: (2023-04-01)

Psychiatric Manifestations in Polycythemia Vera: A Case of Refractory Delirium and Psychosis Responding to Hematological Treatment
by: Yusuf Ezel Yıldırım, et al.
Published: (2025-06-01)

How we treat polycythemia vera
by: V. A. Shuvaev, et al.
Published: (2024-01-01)

Polycythemia and Systemic Manifestations in a 19-year-old Female with SLC30A10 Mutation
by: Adel Fahad Almarzouki, et al.
Published: (2025-01-01)

The effect of polycythemia vera on choroidal thickness and retrobulbar blood flow
by: Nihat Aydın, et al.
Published: (2024-02-01)

A clinical case of cerebellar ataxia with neuropathy and vestibular areflexia syndrome in the presence of polycythemia vera
by: Sh. M. Safin, et al.
Published: (2019-11-01)

Cerebrovascular Accident in a Patient with Polycythemia: a Case Report
by: O. M. Drapkina, et al.
Published: (2022-03-01)

Diagnosis and Treatment of Polycythemia Vera in Pakistan; Barriers and Possible Solutions
by: Rabab Jafry, et al.
Published: (2025-07-01)

Toxic encephalopathy in a clinicl case of polycythemia vera
by: P. I. Kuznetsova, et al.
Published: (2020-01-01)

Population pharmacokinetics and exposure‐response relationship for temsavir following fostemsavir administration in treatment‐experienced HIV patients
by: Ridhi Parasrampuria, et al.
Published: (2025-06-01)

Effects of asfotase alfa on fracture healing of adult patient with hypophosphatasia and literature review
by: Songqi Wang, et al.
Published: (2025-04-01)

Effectiveness of an Instructional Program Concerning Secondary Polycythemia Knowledge on Clients Attending Iraqi National Blood Bank
by: Huda Baker Hassan, et al.
Published: (2016-04-01)

Evaluating the impact of polycythemia vera on retinal and optic nerve head microvascularity: An OCTA study
by: Meryem Feyza Cicek, et al.
Published: (2024-11-01)

Pharmacokinetic and Pharmacodynamic Modeling of Enrofloxacin and Its Metabolite Ciprofloxacin in Pregnant Goats
by: Luis Adrian Ambros, et al.
Published: (2025-06-01)

Myeloproliferative neoplasms working group consensus recommendations for diagnosis and management of primary myelofibrosis, polycythemia vera, and essential thrombocythemia
by: M B Agarwal, et al.
Published: (2015-01-01)

Masked polycythemia vera in a patient 5 years after gastric bypass surgery: A diagnostic pitfall
by: Daniel Rivera, et al.
Published: (2025-02-01)

PET imaging of differentiated thyroid cancer with thyrotropin-alfa
by: Grayson R. Gimblet, et al.
Published: (2025-04-01)